Biotech and Pharmaceuticals
Healthy Returns: Novo Nordisk’s Ozempic faces scrutiny over potential link to rare eye condition
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. There may be a […]
Read More
We’re adding to our position in a stock that just landed a big Wall Street endorsement
Shortly after the opening the bell, we will be buying 300 shares of Bristol Myers Squibb at roughly $56.50. Following the trade, Jim Cramer’s Charitable Trust will own 1,200 shares of BMY, increasing its weighting in the portfolio to roughly 1.9% from about 1.4%. Wall Street’s stretch of bad breadth may have finally caught up […]
Read More
UnitedHealth Group CEO addresses Brian Thompson death, says healthcare system is ‘flawed’
Andrew Witty, CEO, UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America’s Health Care: Assessing the Change Healthcare Cyber Attack and What’s Next,” in Dirksen building on Wednesday, May 1, 2024. Tom Williams | Cq-roll Call, Inc. | Getty Images UnitedHealth Group CEO Andrew Witty on Friday mourned the death of Brian […]
Read More
We want to boost our ownership of a portfolio stock that just boosted its dividend
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Thursday markets: Stocks are taking a breather after Wednesday’s big surge, especially in the Nasdaq Composite and the more narrow “Magnificent Seven” cohort. The yield on […]
Read More
Health care stocks fall as lawmakers, patients push for changes to their business models
UnitedHealth Group signage is displayed on a monitor on the floor of the New York Stock Exchange. Michael Nagle | Bloomberg | Getty Images Shares of major health-care companies fell as much as 5% on Wednesday as investors feared pressure from lawmakers and patients could force changes to their business models. The declining stocks include […]
Read More
Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. […]
Read More
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Patients will be able to access Zepbound single-dose vials at Ro Coutesy: Ro Direct-to-consumer health-care startup Ro on Wednesday said its platform will now offer more affordable single-dose vials of the weight loss drug Zepbound through a new partnership with Eli Lilly, which aims to streamline access to the popular treatment. Ro said it will […]
Read More
Insurance stocks have fallen since UnitedHealthcare CEO’s killing
A banner hanging from on overpass along the southbound lane of I-83 that says, “Deny Defend Depose Health Care 4 All.” Lloyd Fox | Baltimore Sun | Tribune News Service | Getty Images Major insurance stocks have fallen more than 6% since their closing prices last Tuesday, the day before the deadly shooting of Brian […]
Read More
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Wall Street is chewing over critical […]
Read More
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Reuters Prescription fills for blockbuster weight loss drugs in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for the treatments, according to data released Thursday […]
Read More